Hims & Hers Health (HIMS) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

Net selling: insiders sold $4.1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$4.1M net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Sep 30, 2026: 0 added, 1 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about HIMS filings

Are insiders buying or selling Hims Hers Health Inc (HIMS) stock?

Net selling: insiders sold $4.1M and bought $0 of HIMS stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. $4.1M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Okupe, Oluyemi (Chief Financial Officer), who sold $1.7M. The latest filing was on Oct 29, 2026.

Which members of Congress have traded HIMS recently?

None. No member of Congress disclosed a HIMS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HIMS smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

MWMarshall WaceQ3 2026 13FTrimmed
FMFmrQ2 2026 13FAdded$148M
SBBoughtonInsider, filed Oct 29Sold$95.6K
SBBoughtonInsider, filed Oct 15Sold$101K
Top tradersPerpetual positions, not shares1 short$30K

13F: filed up to 45 days late.

Smart money on HIMS

Lean long1 source:
- Influencers
Lean short3 sources:
- Top traders
- Insiders
- Funds

Top traders
- 1 short position, $29.6K
Lean short0 long · 1 short
Open Hyperliquid positions in this stock from the tracked top-trader cohort.
Insiders
Lean short3 sales · $297K
3 of 3 on scheduled plans. Form 4 filings.
Congress
No recent politician filings found
Funds
Lean short1 added · 2 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Influencers
- KaizenInvestor, bullish post, posted Nov 9
Lean long · thin1 post · bullish
Public posts, not disclosed trades.

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about HIMS filings

Are insiders buying or selling Hims Hers Health Inc (HIMS) stock?

Which members of Congress have traded HIMS recently?

None. No member of Congress disclosed a HIMS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HIMS smart-money data?

Funds

What funds are doing

5 moves · 6 mo

Buys/Adds$305.2MSells/Trims$179.2M

Buys/Adds (1)

FM
FMR LLC
Q2 2026 13F
$148.0M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Sells/Trims (2)

MW
Marshall Wace
Q3 2026 13F
$146.2M
sold
Signals like this: n=2239, 53% finished lower at D15, median -0.4% vs SPY -0.4%
SU
Susquehanna
Q2 2026 13F
$32.9M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

2 more moves

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 moves

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 9, 2026

Results versus expectations

Documents

Earnings releaseEX-99.1 All exhibits, including slides8-K Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 9, 2026

Financial period

Q3 2026

GAAP EPS

-$0.14

Company release

Revenue

$890.4M-0.27% miss

$892.8M expected

EPS comparison unavailable.

Q4 2026 guidance

$875.0M to $895.0M

$954.6M expected-7.3%at the midpoint

Next report

What the street expects next

Estimates as of Nov 14, 2026

EPS expected

$0.11

-$0.02 to $0.31

Revenue expected

$954.6M

13 analysts

Last 30 days

0up1down

Analysts cutting estimates

From the release

At a glance

Revenue $890.4M vs $892.8M expected, miss.
GAAP EPS -$0.14 vs $0.06 expected.
Adjusted gross margin 57.0%.
United States revenue $657.1M.
Rest of the World revenue $233.3M.

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 9, 2026	-$0.14Company GAAP	Not comparableDifferent EPS measure	$890.4Mest. $892.8M-0.27%	+48.6%from $599.0M
Jun 30, 2026Reported Aug 10, 2026	-$0.10est. -$0.07	-$0.03miss	$753.2MSEC filing	+38.2%from $544.8M
Mar 31, 2026Reported May 11, 2026	-$0.19est. $0.13	-$0.32miss	$608.1MSEC filing	+3.8%from $586.0M
Dec 31, 2025Reported Feb 23, 2026	$0.22est. $0.19	+20.82%beat	$617.8MAlpha Vantage	+28.4%from $481.1M
Sep 30, 2025Reported Nov 3, 2025	$0.28est. $0.23	+20.42%beat	$599.0MSEC filing	+49.2%from $401.6M
Jun 30, 2025Reported Aug 4, 2025	$0.29est. $0.23	+26.09%beat	$544.8MSEC filing	+72.6%from $315.6M
Mar 31, 2025Reported May 5, 2025	$0.20est. $0.12	+66.67%beat	$586.0MSEC filing	+110.7%from $278.2M
Dec 31, 2024Reported Feb 24, 2025	$0.11est. $0.22	-49.43%miss	$481.1MAlpha Vantage	+95.1%from $246.6M

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Prev close: $19.73
52-wk high: $40.99
52-wk low: $13.74
Mkt cap: $4.62B
ROE: -40.8%
Fwd P/E: 54.0x
Beta: 2.50
P/S: 1.6x
P/B: 13.0x
Profit margin: -6.7%
Op margin: -5.9%

Dec 2025 to Sep 2026

What it sold, what it cost, what was left.

RevenueProfit

Dec 2025Mar 2026Jun 2026Sep 2026

Income statement, 4 periods, all values in US dollars
USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
What came in
RevenueTotal revenue	$617.8M	$608.1M	$753.2M	$890.4M
Cost of what it soldCost of revenue	$173.4M	$307.8M	$272.4M	$381.2M
Gross profit	$444.4M	$300.3M	$480.8M	$509.2M
What it spent
Research and development	$41.0M	$46.9M	$54.9M	$69.4M
Sales and adminSelling, general and administrative	$76.2M	$109.7M	$165.4M	$151.5M
Other operating costsOperating costs not itemised in the filing's summary	$318.1M	$160.1M	$357.7M	$354.5M
Total operating expenses	$435.2M	$316.8M	$578.0M	$575.3M
What was left
Operating profitOperating income	$9.2M	-$16.5M	-$97.2M	-$66.1M
Profit before tax	$18.4M	-$101.6M	-$92.6M	-$46.3M
TaxIncome tax expense	-$2.2M	-$9.4M	-$6.3M	-$13.2M
Net profitNet income	$20.6M	-$92.1M	-$86.3M	-$33.0M
EBITDAEarnings before interest, tax, depreciation, amortisation	$36.4M	-$79.6M	-$63.2M	-$8.0M

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

32balanced

20D volatility

110%annualized

52-week range

$19.73

$13.74$40.99

20D support

$18.40recent floor

20D resistance

$30.13recent ceiling

Returns

5D -18.0%20D -32.8%60D -36.5%

Price vs moving averages

SMA20 -24.7%SMA50 -29.0%SMA200 -26.2%

Volume pace

1.41xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 9, 2026

-$0.14Company GAAP

Not comparableDifferent EPS measure

$890.4Mest. $892.8M-0.27%

+48.6%from $599.0M

Jun 30, 2026Aug 10, 2026

-$0.10est. -$0.07

-$0.03

$753.2MSEC filing

+38.2%from $544.8M

Mar 31, 2026May 11, 2026

-$0.19est. $0.13

-$0.32

$608.1MSEC filing

+3.8%from $586.0M

Dec 31, 2025Feb 23, 2026

$0.22est. $0.19

+20.82%

$617.8MAlpha Vantage

+28.4%from $481.1M

Sep 30, 2025Nov 3, 2025

$0.28est. $0.23

+20.42%

$599.0MSEC filing

+49.2%from $401.6M

Jun 30, 2025Aug 4, 2025

$0.29est. $0.23

+26.09%

$544.8MSEC filing

+72.6%from $315.6M

Mar 31, 2025May 5, 2025

$0.20est. $0.12

+66.67%

$586.0MSEC filing

+110.7%from $278.2M

Dec 31, 2024Feb 24, 2025

$0.11est. $0.22

-49.43%

$481.1MAlpha Vantage

+95.1%from $246.6M

Income statement, 4 periods, all values in US dollars
USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
What came in
RevenueTotal revenue	$617.8M	$608.1M	$753.2M	$890.4M
Cost of what it soldCost of revenue	$173.4M	$307.8M	$272.4M	$381.2M
Gross profit	$444.4M	$300.3M	$480.8M	$509.2M
What it spent
Research and development	$41.0M	$46.9M	$54.9M	$69.4M
Sales and adminSelling, general and administrative	$76.2M	$109.7M	$165.4M	$151.5M
Other operating costsOperating costs not itemised in the filing's summary	$318.1M	$160.1M	$357.7M	$354.5M
Total operating expenses	$435.2M	$316.8M	$578.0M	$575.3M
What was left
Operating profitOperating income	$9.2M	-$16.5M	-$97.2M	-$66.1M
Profit before tax	$18.4M	-$101.6M	-$92.6M	-$46.3M
TaxIncome tax expense	-$2.2M	-$9.4M	-$6.3M	-$13.2M
Net profitNet income	$20.6M	-$92.1M	-$86.3M	-$33.0M
EBITDAEarnings before interest, tax, depreciation, amortisation	$36.4M	-$79.6M	-$63.2M	-$8.0M

USD

Dec 2025

Mar 2026

Jun 2026

Sep 2026

What came in

RevenueTotal revenue

$617.8M

$608.1M

$753.2M

$890.4M

Cost of what it soldCost of revenue

$173.4M

$307.8M

$272.4M

$381.2M

Gross profit

$444.4M

$300.3M

$480.8M

$509.2M

What it spent

Research and development

$41.0M

$46.9M

$54.9M

$69.4M

Sales and adminSelling, general and administrative

$76.2M

$109.7M

$165.4M

$151.5M

Other operating costsOperating costs not itemised in the filing's summary

$318.1M

$160.1M

$357.7M

$354.5M

Total operating expenses

$435.2M

$316.8M

$578.0M

$575.3M

What was left

Operating profitOperating income

$9.2M

-$16.5M

-$97.2M

-$66.1M

Profit before tax

$18.4M

-$101.6M

-$92.6M

-$46.3M

TaxIncome tax expense

-$2.2M

-$9.4M

-$6.3M

-$13.2M

Net profitNet income

$20.6M

-$92.1M

-$86.3M

-$33.0M

EBITDAEarnings before interest, tax, depreciation, amortisation

$36.4M

-$79.6M

-$63.2M

-$8.0M

Hims Hers Health Inc

Smart money at a glance

What do analysts expect?

Questions about HIMS filings

Smart money on HIMS

Questions about HIMS filings

What funds are doing

What insiders are doing

What fin-fluencers are saying

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

At a glance

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Hims Hers Health Inc

Smart money at a glance

What do analysts expect?

Questions about HIMS filings

Smart money on HIMS

Questions about HIMS filings

What funds are doing

What insiders are doing

What fin-fluencers are saying

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

At a glance

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Hims Hers Health Inc

Overview

Questions about HIMS filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Hims Hers Health Inc

Overview

Questions about HIMS filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.